ClinicalTrials.gg
Sign In

Lupus Erythematosus, Cutaneous clinical trials

The registry lists 67 studies for Lupus Erythematosus, Cutaneous across more than 10 countries. 18 are recruiting or about to start. 41 of them are mainly about Lupus Erythematosus, Cutaneous (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-12. Counting its narrower condition Lupus Erythematosus, Discoid too: 87 studies, 20 open.

Get an email when these change. Save the Lupus Erythematosus, Cutaneous studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
30
Recruiting
12
Terminated
9
Active, not recruiting
6
Not yet recruiting
4
Enrolling by invitation
2

Phase

Phase 2
26
Phase 1
16
Phase 3
10
Early Phase 1
3

Where

United States
39
Germany
23
Poland
17
Spain
15
Bulgaria
13
China
12

Who runs them

Gilead Sciences (4) · EMD Serono Research & Development Institute, Inc. (4) · Biogen (4) · Amgen (3) · University of Pennsylvania (3) · Bristol-Myers Squibb (3) · European Society of Cutaneous Lupus Erythematosus e.V. (2) · Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany (2)

What is being tested here

Drugs under test in Lupus Erythematosus, Cutaneous studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Enpatoran336
Litifilimab123
Afimetoran112
Lenalidomide112
Tapinarof101
Quinacrine101
ICP-488101
Imiquimod101
Daxdilimab002
Anifrolumab011

Coming up

8phase 3 studies under way
9studies finish main data collection within a year1 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 9, phase 3 first

Who these studies take

Of the 12 Lupus Erythematosus, Cutaneous studies recruiting now, 4 (33%) set no upper age limit and 7 (58%) stop at 75 or younger. 2 (17%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 3 (25%) take healthy volunteers.

Recruiting studies that take each age, of 12
AgeWomenMen
101 (8%)1 (8%)
1812 (100%)12 (100%)
3012 (100%)12 (100%)
4012 (100%)12 (100%)
5012 (100%)12 (100%)
6511 (92%)11 (92%)
759 (75%)9 (75%)
854 (33%)4 (33%)

Across all 67 studies, recruiting or not: 54% stop at 75 or younger and 15% at 65; 3% take children; 1% are for women only and 0% for men only; 18% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

What changed recently

From the registry's own updates since Oct 14, 2026.

Started recruiting2

Newly registered2

Studies

Recruiting first, then most recently updated. Showing 50 of 67. Browse all 67 → or search them.